Birth Control News and Research

RSS

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

To stop Planned Parenthood clinics from receiving public financing, Texas' Republican leaders gambled that the state could operate a contraception and cancer-screening program for low-income women without tens of millions of federal dollars. But with the exclusion of about 40 Planned Parenthood clinics -- none of which performed abortions -- from the Texas Women's Health Program in 2013, records showed that claims for birth control and wellness exams dropped, as did enrollment numbers (Aaronson, 12/12).

16 Dec 2013

First Edition: December 13, 2013

Today's early morning highlights from the major news organizations, including reports about a set of steps taken by the Obama administration in an effort to help consumers avoid coverage lapses as the health law takes effect.

13 Dec 2013

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from two studies of REVLIMID (lenalidomide) combinations in patients with diffuse large B-cell lymphoma (DLBCL) were presented at the American Society of Hematology annual meeting in New Orleans, La.

11 Dec 2013

New findings on effects of epilepsy on mother and child

New research pertaining to the latest findings on the effects of epilepsy on both the mother and child were presented at the American Epilepsy Society's 67th Annual Meeting in Washington DC. These studies explore folic acid use, the effect of surgery with intractable focal epilepsy, and antiepileptic drug exposure during breastfeeding.

10 Dec 2013

Two intrauterine contraceptive systems safe and effective in preventing pregnancies

In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

5 Dec 2013

Federal judge hears arguments on health law subsidies

Millions of people in 34 states could be denied government subsidies to help them pay for insurance if the latest lawsuit brought by the opponents of the health law is successful.

5 Dec 2013

First Edition: December 4, 2013

Today's headlines spotlight the White House's push to defend the health law and advance positive messages about its benefits.

4 Dec 2013

Viewpoints: SCOTUS should support contraception mandate; our brains 'not wired' for Obamacare; President's personality impairs law's success

More than a year after it upheld the constitutionality of the Affordable Care Act, the Supreme Court has set the stage for a showdown over the law's requirement that employer health plans cover birth control.

28 Nov 2013

Supreme Court to hear arguments on health law's contraceptive coverage mandate

The justices accepted a pair of cases that raise questions not just about religious freedom and equality for female employees, but whether the religious beliefs of the owners of secular corporations allows them to not comply with a law.

27 Nov 2013

First Edition: Nov. 27, 2013

Kaiser Health News staff writer Phil Galewitz, in collaboration with McClatchy, reports: "Like half the states, South Carolina chose not to expand Medicaid under the federal health law next year, citing the program's high costs and inefficiency. Yet, state officials still forecast a 16 percent enrollment jump by the end of June, 2015, triple that of a typical year and even higher than the 12 percent average increase expected in states that are expanding eligibility.

27 Nov 2013

Supreme Court mulls taking health law contraception case

The justices could announce as early as Tuesday whether they will review provisions in the Affordable Care Act requiring employers of a certain size to offer insurance coverage for birth control and other reproductive health services without a co-pay. The owners of more than three dozen for-profit companies have argued that complying with that provision would violate their religious beliefs.

27 Nov 2013

State exchanges report November surge

Still, reports on the ground vary -- with some states offering positive news, while others still are limping along. Here is a sampling of coverage from Kentucky, Minnesota, Illinois, Colorado, Hawaii, Oregon and Massachusetts.

26 Nov 2013

First Edition: November 25, 2013

Today's headlines include reports about how political concerns and strategies are taking shape as a result of healthcare.gov's difficulties.

25 Nov 2013

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected adults with compensated liver disease, including cirrhosis.

23 Nov 2013

Contraception coverage, abortion loom as issues for high court and advocacy groups

Advocacy groups are wondering about a future boomerang affect of the "nuclear option," which could keep Senate Republicans from filibustering judicial nominations.

20 Nov 2013

Research shows oral contraceptive use over three years could be a risk factor for glaucoma

Research presented today, at the 117th Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading causes of blindness which affects nearly 60 million worldwide. The researchers caution gynecologists and ophthalmologists to be aware of the fact that oral contraceptives might play a role in glaucomatous diseases, and inform patients to have their eyes screened for glaucoma if they also have other risk factors.

19 Nov 2013

Women’s recovery from concussions may depend on menstrual cycle

How well a woman recovers from a concussion may depend on that time of the month.

14 Nov 2013

Health law outreach efforts try new controversial ads, enrollment tactics

Health law outreach efforts take on new wrinkles -- Colorado officials launch controversial ads geared toward women and Enroll America changes how it tries to get people to sign up for health coverage. In the meantime, Republicans are releasing their own set of ads mocking the law.

13 Nov 2013

First Edition: November 13, 2013

Today's headlines include not-so-positive predictions about whether healthcare.gov will be fully functional by the end of November.

13 Nov 2013

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.

12 Nov 2013

Birth Control News and Research

State highlights: Fewer visits to Texas women's clinics after planned parenthood exclusion; Minn. health spending growth slows

First Edition: December 13, 2013

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

New findings on effects of epilepsy on mother and child

Two intrauterine contraceptive systems safe and effective in preventing pregnancies

Federal judge hears arguments on health law subsidies

First Edition: December 4, 2013

Viewpoints: SCOTUS should support contraception mandate; our brains 'not wired' for Obamacare; President's personality impairs law's success

Supreme Court to hear arguments on health law's contraceptive coverage mandate

First Edition: Nov. 27, 2013

Supreme Court mulls taking health law contraception case

State exchanges report November surge

First Edition: November 25, 2013

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Contraception coverage, abortion loom as issues for high court and advocacy groups

Research shows oral contraceptive use over three years could be a risk factor for glaucoma

Women’s recovery from concussions may depend on menstrual cycle

Health law outreach efforts try new controversial ads, enrollment tactics

First Edition: November 13, 2013

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News